It's not that you're charging for API access; it's that you're charging US pharmaceutical industry pricing levels ($12,000 for something that should realistically be $200) and then only giving devs such a short time to implement changes. This was designed to kill 3PApps outright and everyone can see it. What an ass.
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
replies: